An exploration of anaemia in low-birthweight infants exposed to perinatal zidovudine at the neonatal unit at a regional hospital in Durban

References

• MacDonald M, Yadler R. Maternal child and women’s health summit by Dr Aaron Motsoaledi. 2009.
   Google Scholar
• Kak L Chitsike ILuo C Rollins N. Prevention of Mother-to-Child Transmission of HIV/AIDS Programmes, Opportunities for Africa’s Newborns. 2011;113–126
   Google Scholar
• Connor EM, Sperling RS, Gelber R, et al. Paediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331: 1173–80.10.1056/NEJM199411033311801
   PubMed Web of Science ®Google Scholar
• Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard nevirapine to prevent mother to child transmission of HIV-1 in Thailand. New Eng J Med. 2004;351(3): 217–28.10.1056/NEJMoa033500
   PubMed Web of Science ®Google Scholar
• Draper B, Abdullah F. A review of the prevention-of-mother-to-child-transmission programme of the Western Cape provincial government, 2003-2004. S Afri Med J. 2008;98(6): 431–42.
   PubMed Web of Science ®Google Scholar
• DOH Clinical guidelines. The South African antiretroviral treatment guidelines. National Department of Health SA: PMTCT guidelines revised; 2013.
   Google Scholar
• DOH Clinical guidelines: prevention of mother to child transmission. National Department of Health SA. 2010.
   Google Scholar
• Moyle G, Sawyer W, Law M, et al.. Changes in haematological parameters and efficacy of thymidine-analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomised, comparative studies. Clin Ther. 2004;26(1): 92–7.10.1016/S0149-2918(04)90009-4
   PubMed Web of Science ®Google Scholar
• Sperling RS, Shapiro DE, McSherry GD, et al. Safety of maternal-infant zidovudine utilized in the Paediatric AIDS Clinical Trial Group 076 Study .AIDS 1998;12(14):1805–09. (London, England) .10.1097/00002030-199814000-00012
   PubMed Web of Science ®Google Scholar
• Lahoz R, Noguera A, Rovira Nu, et al. Antiretroviral-related haematological short-term toxicity in healthy infants - implications of the new neonatal 4 week zidovudine regimen. Paediatr Infect Dis J. 2010;29(4): 376–9.
   PubMed Web of Science ®Google Scholar
• Taha TE, Kumwenda N, Gibbons A, et al. Effect of HIV-1 antiretroviral prophylaxis on hepatic and haematological parameters of African infants. . AIDS.2002;16(6):851–8. (London, England).10.1097/00002030-200204120-00004
   PubMed Web of Science ®Google Scholar
• Taha TE, Kumwenda N, Kafulafula G, et al. Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth. Ann Trop Paediatr. 2004;24(4):301–9.10.1179/027249304225019127
   PubMed Web of Science ®Google Scholar
• Ziske J, Kunz A, Sewangi J, et al. Haematological changes in women and infantsexposed to an AZT-containing regimen for prevention of mother to child transmission of HIV in Tanzania. PLoS One. 2013;8(2):e55633.10.1371/journal.pone.0055633
   Google Scholar
• PROMISE IMPAACT 1077BF ongoing randomized clinical trial. 2010.
   Google Scholar
• Fanaroff AA, Martin RJ, Walsh MC. Fanaroff and Martin’s Neonatal perinatal medicine, Diseases of the fetus and infant. 9th ed. JFletcher editor. St. Louis, MI: Elsevier Mosby. (vol 2) 2011. p. 1309 –10
   Google Scholar
• Newland AC, Evans TGJR. ABC of clinical haematology: haematological disorders at the extremes of life. Br Med J. 1997;314(7089):1262–65.10.1136/bmj.314.7089.1262
   PubMed Web of Science ®Google Scholar
• DHIS data 2010/11. Extracted January 2012
   Google Scholar
• Zegers M, de Bruijne M, Spreeuwenberg P, Wagner C, Groenewegen P, van der Wal G. Quality of patient record keeping: an indicator of the quality of care? BMJ Qual Saf. 2011;20(4):314–8.10.1136/bmjqs.2009.038976
   PubMed Web of Science ®Google Scholar
• Fitzgerald FC, Bekker LG, Kaplan R, et al.. Mother to child transmission in a community based antiretroviral clinic in South Africa. S Afr Med J. 2010;100:827–31.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Towards Universal Access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization; 2008.
   Google Scholar
• Sibeko S, Moodley J. Health care attendance patterns by pregnant women in Durban, South Africa. SA Fam Pract. 2006;48(10):17–17e.
   Google Scholar
• Republic of South Africa. National Strategic Plan on HIV, STIs and TB: 2012–2016. SANAC:Pretoria; 2011.
   Google Scholar
• Division of AIDS Table for Grading the Severity of Adult and Paediatric Adverse Events. Version 1.0, December, 2004.
   Google Scholar
• Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;343(14):982–91.10.1056/NEJM200010053431401
   PubMed Web of Science ®Google Scholar
• Volmink J, Siegfried NVan de Merwe LBrocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews [Internet; Peer Reviewed; UK & Ireland]. 2007.
   Google Scholar